Allurion Technologies Shares Are Up Today: What's Going On?

1. Allurion plans a clinical study with GLP-1 agonists for weight loss. 2. GLP-1 treatments may cause significant muscle loss in patients. 3. Previous studies show Allurion's balloon helps preserve muscle during weight loss. 4. The company aims to confirm a healthier weight loss combination. 5. Allurion has a securities purchase agreement to raise $7.4 million.